• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Mixing 2 injections controls blood glucose as well as injecting separately

Article

Mixing insulin detemir with aspart is equivalent to giving the 2 medications as separate injections in children with type 1 diabetes.

Mixing insulin detemir with aspart is equivalent to giving the 2 medications as separate injections in children with type 1 diabetes, according to research published online May 26 in Diabetes Care.

In this study, 14 children with type 1 diabetes were randomly assigned to receive either mixed insulin injections or separate insulin injections for the first 10 days; they then crossed over for the last 10 days. Patients underwent continuous glucose monitoring during the last 72 hours of the study. At the end of the study, patients had equivalent blood glucose levels regardless of how their insulin had been delivered (48-hour area under the curve [AUC], mixed insulins: 457±70 mmol•h/L; separate insulins: 469±112 mmol•h/L; P=.58), suggesting that combining insulins into 1 injection should be as effective at controlling blood glucose levels as injecting insulins separately.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.